Effects of Four Different Hormone Replacement Therapy Regimens on Certain Cardiovascular Risk Factors

This study was performed to compare the effects of 4 different hormone replacement therapy (HRT) protocols on certain cardiovascular risk factors. Eighty- nine postmenopausal women were treated with oral conjugated estrogens, transdermal 17 beta-E2, cyclic oral E2-17- valerate+cyproterone acetate (E2-17-V+CA) or tibolone. Blood pressure (BP) measurements, fasting blood glucose (FBG), serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL) and triglyceride levels at the 12th month were compared with the pretreatment values in each treatment group. There were no significant changes in the systolic BP, FBG, serum total and LDL-cholesterol levels in any group. Diastolic BP measurements were lower in the E2-17-V+CA group; HDL-cholesterol levels increased in the conjugated E and E2- 17-V+CA groups; and triglyceride levels decreased in the tibolone group significantly (p0.05). Therefore, these HRT protocols were not significantly different from one another in eliminating certain cardiovascular risk factors.

Effects of Four Different Hormone Replacement Therapy Regimens on Certain Cardiovascular Risk Factors

This study was performed to compare the effects of 4 different hormone replacement therapy (HRT) protocols on certain cardiovascular risk factors. Eighty- nine postmenopausal women were treated with oral conjugated estrogens, transdermal 17 beta-E2, cyclic oral E2-17- valerate+cyproterone acetate (E2-17-V+CA) or tibolone. Blood pressure (BP) measurements, fasting blood glucose (FBG), serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL) and triglyceride levels at the 12th month were compared with the pretreatment values in each treatment group. There were no significant changes in the systolic BP, FBG, serum total and LDL-cholesterol levels in any group. Diastolic BP measurements were lower in the E2-17-V+CA group; HDL-cholesterol levels increased in the conjugated E and E2- 17-V+CA groups; and triglyceride levels decreased in the tibolone group significantly (p0.05). Therefore, these HRT protocols were not significantly different from one another in eliminating certain cardiovascular risk factors.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Effects of Four Different Hormone Replacement Therapy Regimens on Certain Cardiovascular Risk Factors

Erdal MALATYALIOĞLU, Tayfun ALPER, Filiz F. YANIK, Arif KÖKÇÜ

Production and Characterization of Monoclonal Anti-Ovalbumin Antibodies

Mehmet Ziya DOYMAZ, Aykut ÖZDARENDELİ, Hakan BULUT, Yusuf BOLAT

Comparative Study of Dopamine and Mannitol Effects on Renal Function During Cardiopulmonary Bypass by Using N-acetyl-b-D-glucosaminidase Assay

Onur DURAL

High-Dose Intravenous Immunoglobulin Treatment in Intractable Childhood Epilepsy

Nedret URAN, Tuğrul ÖZCAN, Sema KALKAN, Gül SERDAROĞLU, Erkin SERDAROĞLU

A case of carbamazepine-induced lymphocytic interstitial pneumonitis

Ömer DENİZ, Erkan BOZKANAT, Faruk ÇİFTÇİ, Ahmet İLVAN, Ergun TOZKOPARAN, Sami ÖZTÜRK

Leukocytosis as a parameter in management of organophosphate intoxication

Muhammet GÜVEN, Hülya TAŞKAPAN, Mustafa ÇETİN, Ayhan DOĞUKAN

The radioprotective effect of vitamins C, E and vitamin E + glutathione on the small intestine and the thyroid gland in rats irradiated with X-rays

Cemil SERT, Yusuf NERGİZ, Zülküf AKDAĞ, M. Salih ÇELİK, M. Aydın KETANİ

Clinical Efficacy of Topical Clindamycin Phosphate and Azelaic Acid on Acne Vulgaris and Emergence of Resistant Coagulase-Negative Staphylococci

Metin ÖZKAN, Gül DURMAZ, Yurdanur AKGÜN, İlham SABUNCU, Nurhan SARAÇOĞLU, Selim Murat ÜRER

Investigation of Various Terminal Carbohydrate Structures in Apolipoproteins of Human Serum Chylomicrons and VLDL

Tayfun GÜLDÜR, Tülay İLERİ, Ramazan YILMAZ

Contralateral White Noise-Induced Enhancement in the Guinea PigÕs MLR: A Possible Link to Direc- tional Hearing

Cüneyt GÖKSOY